Information about Syngle Therapeutics
My details
*
*
*

Syngle Therapeutics (BV)

NL

77736451

Company information

Status
Active

KVK number

77736451

VAT Number

NL 861117189 B01
Established
27-03-2020
Last balance sheet year
2024
Company size
Micro 0 FTE
Legal form
Besloten Vennootschap (BV)
RSIN number
861117189
Principal activity
Research and experimental development on natural sciences and engineering
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Syngle Therapeutics

2024 2023 2022 2021
Balance sheet
Balance sheet total € 144.409 237% € 42.899 2% € 42.186 61% € 26.229
Equity € -37.472 -3% € -36.453 -36% € -26.794 -25% € -21.444
Debts € 181.881 129% € 79.352 15% € 68.980 45% € 47.673
Other
Employees 0 0 0 0

Frequently asked questions

What is the KVK number of Syngle Therapeutics?
The KVK number of Syngle Therapeutics is 77736451
What is the VAT number of Syngle Therapeutics?
The VAT number of Syngle Therapeutics is NL 861117189 B01.
Wat is the PEPPOL ID of Syngle Therapeutics?
There is no information available about the PEPPOL ID of Syngle Therapeutics or the company is not yet registered on the PEPPOL network.
When was Syngle Therapeutics founded?
Syngle Therapeutics was founded on 27-03-2020.
What is the address of Syngle Therapeutics?
The current registered office of Syngle Therapeutics is located at Claroenstekerpad 19, 3766 BX Soest.
When was the last time Syngle Therapeutics filed their annual financial statements?
The most recent financial statements of Syngle Therapeutics were filed on 31-12-2024.
How many employees does Syngle Therapeutics have?
There are currently no employees working at Syngle Therapeutics or no workforce information is available.
What is the annual turnover of Syngle Therapeutics?
There is no turnover available for Syngle Therapeutics.

Sources